Antiparkinson Drugs Flashcards

1
Q

PD causes, risk facotrs, cardinal symptoms

A

95% idio patic…5% familia

Positive - age, heredity, sex, toxic

Negative - coffee, tobacco, NSAIDs

Resting tremor - pill rolling
Muscular cogwheel rigidity
Bradykineia - slowness and restricteed movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pathology, why survival time, and reflex vs. coluntary

A

Loss of dopamanergic in SN
Hallmark lewy bodies
>80% loss before symtoms

Mitchondrial dysfunction, ROS, excititoxic glutamate exposure

3-5 yrs untreated
5-10 yrs tx

Reflexes intact but voluntayr slower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PD subtypes

A

PD - less common…tremor main complaint…younger patients…slower

PDD - postural imabalance and gait…>70 y/o at diagnosis…akinesia, rigidity…rapid decline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Parkinsonism

A

Drug induced PD symptoms (due to DA antagonists like antipsychotics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MPTP

A

MPTP protoxin taken up by DAergic neurons via transporter…converted to MPP+ by MAOB in astrocytes…MPP+ interferes with mitochondria…free radical uidup and death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Levodopa/L-Dopa mech and rationale

A

DA does not cross BBB

Prodrug has no action…crosses the BBB (unlike DA)…decarboxylated ti DA in ingrostriatal neurons…seuqestered in vesicles avaiable for release into DA deprived striatum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dopamine creation

A

Tyroosine to L-dopa to dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

L-DOPA therapeutics

A

Gold standard
Efficacy decreases as disease progresses
NEver given alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

L-DOPA kinetics

A

AA in diet compete iwht L-DOPA for transport

Metabolized to HVA and DOPAC

1-3% into CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical use and side effects of LDOPA

A

On target effects weaken and side effects strengthen as dz progresses…best early

Peripheral (because of L-DOpa to DOpa conversion)…GI distrubrances because of DOPA decarboylase in gut…tachycardia and hypotension

Central - wearing off (associated with dosing schedule), on/off(NOT associated with dosing scheudle), abnormal involuntary movements, psychotomimetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

L-Dopa interactions and contraindiciations

A

Vit B6 (enhances metabolism) or within 2 weeks of MAOA (hypertensive crisis)

Psychosis, glaucoma, cardiac dz, peptic ulcers, melanoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Carbidopa

A

L-DOPA given with
DOes not cross BBB
Reduces Nausea and CV effects
IMproves delivery to CNS

DOpa decarbozylase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Rationale of COMT inhibitors

A

Inhibiting peripheral DOPA decarbozylase upregulates COMT…converts L-DOPA to 3OMD…competes with L-DOPA for BBB transport to CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Entacapone, stalevo with side effects

A

Preferred…does not cross BBB
Entacopone + carbidopa+L-DOPA

Organge colored urine is main one

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Dopamine agnosits advantage and disadvantages

A
Do not require nigrostriatal neurons or metabolic conversion
Longer duration
Selective for D2 subtype
Do not conpete for trnapsort 
Can be monotherapeutic 

Not under neuronal control
Off target

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dopamine agnost side effect

A

N/V, sleepiness, insomnia, AIMs

17
Q

Bromocriptine

A
Absorbed in gut 
Peak in 1-2 horus 
Excreted in bile and feces 
Ergot based
Newer, non-ergot DA agnoists are preferred
18
Q

Pramipexole

A

Antioxidant free radical svaneger
May be neuroprotective
Excreted by kindey
Renal insufficiency could be problem

19
Q

Ropinirole

A

Metabolized by CYP1A2…competing could slow clearance

20
Q

Pramiprexole and ropinirole are both

A

DA2 type agnosits
Slow titration needed
Monotherapy for mild

21
Q

Rotigotine

A

One daily pathc
Binds D3 more strongly
DA2>DA1

22
Q

APomorphine mech, indicaion, pharmacokinetics, side effects

A

Potent non selective DA agonist
Relief of the off state
Delivered subq…lasts 2 hours…quick acting
Nausea

23
Q

DA agonist side effects and contraindications

A

GI (N/V constipation)
CV (hypotension with vasospasm)
Dyskinesia
Mental disturbance

Psychosis, MI, peripheral ascular dz (for ergot)

24
Q

MAOI rationale

A

MAOB inhibition will increase DA avialbility and lower ox strsss

25
Q

Selegiline mech and side effedcts

A

Selective and irreversible MAOB

Modd elevating, N/V, dry mouth

26
Q

Amantadine

A

Rduces dyskinesia late in PD progression
Adjunct iwht sinemet
Worry about renal dz
Similar to L-DOPA side effects

Contra with history of seizure or heart failure

27
Q

Muscarinic antagonist

A

Reducing Ach can balance Ach:DA ration

No effect on brady kinesia but can reduce tremor and rigidity

Start low and tritrate up

28
Q

Trihexyphenidyl

A

Muscarinic antagonist